Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
argenx
Pharma
AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods
Continuing to harvest a bounty approvals, AZ scored nods for its C5 inhibitor to treat generalized myasthenia gravis on both sides of the Atlantic.
Fraiser Kansteiner
Nov 16, 2026 10:39am
Argenx reports Q3 sales bump and a new trial requirement
Oct 23, 2026 11:42am
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Oct 8, 2026 10:44am
Argenx preps next potential Vyvgart nod after ph. 3 win
Aug 17, 2026 10:52am
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am